Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
EHC 2024
Programm
Poster
Suche
DE
Alle Personen
Andreas R. Gantenbein
Sortiert nach Typ
Datum
Vortrag
ePoster
P082
Impact of Atogepant on achieving complete improvement as early as week 1 based on the Activity impairment in Migraine-Diary (AIM-D) domains: post hoc analysis from the ADVANCE, ELEVATE, and PROGRESS trials
Weitere Beteiligungen
ePoster
P076
Impact of Atogepant on daily functioning in patients with episodic migraine and chronic migraine: Activity Impairment in Migraine-Diary (AIM-D) Item-Level analysis
ePoster
P082
Impact of Atogepant on achieving complete improvement as early as week 1 based on the Activity impairment in Migraine-Diary (AIM-D) domains: post hoc analysis from the ADVANCE, ELEVATE, and PROGRESS trials
ePoster
P148
Fremanezumab for the prevention of menstrually-related migraine attacks – a prospective observational phase 4 study according to routine neurological care in Switzerland (FROMM)
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz